Spectrum of cognition short of dementia: Framingham Heart Study and Mayo Clinic Study of Aging

Neurology

Volumn 85, Issue 19, 2015, Pages 1712-1721

  Knopman, David S ^a   Beiser, Alexa ^c,d   Machulda, Mary M ^a   Fields, Julie ^a   Roberts, Rosebud O ^a,b   Pankratz, V Shane ^b   Aakre, Jeremiah ^b   Cha, Ruth H ^b   Rocca, Walter A ^a,b   Mielke, Michelle M ^b   Boeve, Bradley F ^a   Devine, Sherral ^c   Ivnik, Robert J ^a   Au, Rhoda ^c   Auerbach, Sanford ^c   Wolf, Philip A ^c   Seshadri, Sudha ^c   Petersen, Ronald C ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; AMNESIA; ATTENTION; COGNITION; CONSENSUS; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; EXECUTIVE FUNCTION; FEMALE; FRAMINGHAM RISK SCORE; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; VERY ELDERLY; COGNITIVE DYSFUNCTION; COHORT ANALYSIS; DISEASE COURSE; HEALTH SURVEY; LONGITUDINAL STUDY; PATHOLOGY; PSYCHOLOGY;

AGED; AGED, 80 AND OVER; AGING; COGNITION; COGNITIVE DYSFUNCTION; COHORT STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 84946908451     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002100     Document Type: Review

References (41)

1. Manly JJ, Tang MX, Schupf N, et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494-506.
2. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel-Heller SG. Mild cognitive impairment: long-term course of four clinical subtypes. Neurology 2006;67:2176-2185.
3. Lopez OL, Kuller LH, Becker JT, et al. Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol 2007; 64:416-420.
4. Lopez OL, Becker JT, Chang YF, et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology 2012;79: 1599-1606.
5. Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology 2012;79:1591-1598.
6. Ganguli M, Snitz BE, Saxton JA, et al. Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol 2011;68:761-767.
7. Fischer P, Jungwirth S, Zehetmayer S, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007;68:288-291.
8. Saxton J, Snitz BE, Lopez OL, et al. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry 2009;80:737-743.
9. Ritchie LJ, Tuokko H. Clinical decision trees for predicting conversion from cognitive impairment no dementia (CIND) to dementia in a longitudinal population-based study. Arch Clin Neuropsychol 2011;26:16-25.
10. Ravaglia G, Forti P, Montesi F, et al. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J Am Geriatr Soc 2008;56:51-58.
11. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 2008;148:427-434.
12. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882-1891.
13. Palmer K, Backman L, Winblad B, Fratiglioni L. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008;16:603-611.
14. Han JW, Kim TH, Lee SB, et al. Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement 2012;8:553-559.
15. Peters ME, Rosenberg PB, Steinberg M, et al. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am J Geriatr Psychiatry 2013;21:1116-1124.
16. Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a populationbased prospective cohort. Neurology 2002;59:1594-1599.
17. Luck T, Luppa M, Wiese B, et al. Prediction of incident dementia: impact of impairment in instrumental activities of daily living and mild cognitive impairment-results from the German Study on Ageing, Cognition, and Dementia in Primary Care Patients. Am J Geriatr Psychiatry 2012;20:943-954.
18. Di Carlo A, Lamassa M, Baldereschi M, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909-1916.
19. Roberts RO, Geda YE, Knopman D, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008;30:58-69.
20. Au R, Seshadri S, Wolf PA, et al. New norms for a new generation: cognitive performance in the Framingham offspring cohort. Exp Aging Res 2004;30:333-358.
21. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
23. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
24. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
25. Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology 2014;82: 317-325.
26. Petersen RC, Caracciolo B, Brayne C, et al. Mild cognitive impairment: a concept in evolution. J Intern Med 2014; 275:214-228.
27. Murray ME, Graff-Radford NR, Ross OA, et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011;10:785-796.
28. Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA. Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol 2006;63:218-221.
29. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993;43: 515-519.
30. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-V. Washington, DC: American Psychiatric Association; 2013.
32. Weintraub S, Mesulam MM. Four neuropsychological profiles of dementia. In: Boller F, Grafman J, editors. Handbook of Neuropsychology. Amsterdam: Elsevier; 1993.
33. Kohler S, Hamel R, Sistermans N, et al. Progression to dementia in memory clinic patients without dementia: a latent profile analysis. Neurology 2013;81:1342-1349.
34. Libon DJ, Xie SX, Eppig J, et al. The heterogeneity of mild cognitive impairment: a neuropsychological analysis. J Int Neuropsychol Soc 2010;16:84-93.
35. Bondi MW, Edmonds EC, Jak AJ, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis 2014;42:275-289.
36. Sperling RA, Aisen P, Beckett L, et al. Toward defining the preclinical stage of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
37. Petersen RC, Aisen P, Boeve BF, et al. Mild cognitive impairment due to Alzheimer's disease: criteria in the community. Ann Neurol 2013;74:199-208.
38. Prestia A, Caroli A, van der Flier WM, et al. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology 2013;80: 1048-1056.
39. Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE. Extension and refinement of the predictive value of different classes of markers in ADNI: fouryear follow-up data. Alzheimers Dement 2014;10: 704-712.
40. Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DM. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc 2011;59:1612-1617.
41. Albert M, De Kosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: report of the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-279.